Non-Hallucinogenic Psychedelics: A New Treatment for Mental Health Disorders

Explore groundbreaking research on non-hallucinogenic psychedelic treatments for mental health disorders in this 32-minute video lecture from The University of Chicago. Join Associate Professor David E. Olson, founding director of the UC Davis Institute of Psychedelics and Neurotherapeutics, as he delves into the biology and chemistry behind psychedelic drugs and their therapeutic potential. Learn about innovative approaches to treating depression, anxiety disorders, and addiction through next-generation neurotherapeutics that aim to harness the benefits of psychedelics without their hallucinogenic effects. Discover the mechanisms of how these compounds affect the brain, understand the current mental health crisis context, and examine the development of novel treatments like TBG. Gain insights into the controversies surrounding microdosing, the role of ketamine in psychedelic research, and receive practical guidance for those interested in psychedelic therapies.